
Sunday, February 25, 2018 6:55:28 PM
In My Own Personal Opinion Of Course!

Liked By
Spread the love. Be the first to like this post!
Recent CYDY News
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/08/2023 10:16:28 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/02/2023 10:16:29 PM
- Notice of Effectiveness (effect) • Edgar (US Regulatory) • 02/10/2023 11:12:51 AM
- Notice of Effectiveness (effect) • Edgar (US Regulatory) • 02/10/2023 11:12:34 AM
- Notice of Effectiveness (effect) • Edgar (US Regulatory) • 02/10/2023 11:11:19 AM
- Notice of Effectiveness (effect) • Edgar (US Regulatory) • 02/10/2023 11:10:56 AM
- Notice of Effectiveness (effect) • Edgar (US Regulatory) • 02/10/2023 11:10:55 AM
- Notice of Effectiveness (effect) • Edgar (US Regulatory) • 02/10/2023 11:09:37 AM
- Notice of Effectiveness (effect) • Edgar (US Regulatory) • 02/10/2023 11:09:32 AM
- Notice of Effectiveness (effect) • Edgar (US Regulatory) • 02/10/2023 11:09:29 AM
- Post-effective Amendment to Registration Statement (pos Am) • Edgar (US Regulatory) • 02/03/2023 10:23:17 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 02/01/2023 10:16:24 PM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 01/09/2023 10:30:29 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 12/19/2022 10:20:44 PM
- Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 12/07/2022 04:04:32 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 12/07/2022 04:02:07 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 12/07/2022 11:02:17 AM
- Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 12/07/2022 11:01:33 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 11/25/2022 10:16:33 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 11/17/2022 11:54:40 PM
ILUS Confirms Further Funding Arrangements and Note Settlement • ILUS • Mar 31, 2023 10:21 AM
Sigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-K • SIGY • Mar 31, 2023 10:06 AM
Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer's and Parkinson's Disease and Related Neurological Disorders Conference • TLSA • Mar 31, 2023 7:07 AM
ARway Secures Multiple New SDK Deals to Drive Growth in $44B Indoor Positioning and Navigation Market • ARWYF • Mar 30, 2023 10:30 AM
Nextech3D.ai Enters Asian Market with Major 3D Modeling Deal to Revolutionize E-Commerce • NTAR • Mar 30, 2023 10:00 AM
OMID Posts 2022 Annual Report and Provides Update • OMID • Mar 30, 2023 9:15 AM